Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer.

Misraï V, Rouprêt M, Chartier-Kastler E, Comperat E, Renard-Penna R, Haertig A, Bitker MO, Richard F, Conort P.

World J Urol. 2008 Oct;26(5):481-5. doi: 10.1007/s00345-008-0286-8. Epub 2008 Jun 26.

PMID:
18581118
2.

Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.

Pfeiffer D, Berger J, Gross AJ.

BJU Int. 2012 Dec;110(11):1702-7. doi: 10.1111/j.1464-410X.2012.11375.x. Epub 2012 Aug 29.

3.
4.

High-intensity focused ultrasound therapy for clinically localized prostate cancer.

Lee HM, Hong JH, Choi HY.

Prostate Cancer Prostatic Dis. 2006;9(4):439-43. Epub 2006 Jul 18.

PMID:
16847468
5.

Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer.

Blana A, Rogenhofer S, Ganzer R, Lunz JC, Schostak M, Wieland WF, Walter B.

Urology. 2008 Dec;72(6):1329-33; discussion 1333-4. doi: 10.1016/j.urology.2008.06.062. Epub 2008 Oct 1.

PMID:
18829078
6.

PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer.

Ganzer R, Rogenhofer S, Walter B, Lunz JC, Schostak M, Wieland WF, Blana A.

Eur Urol. 2008 Mar;53(3):547-53. Epub 2007 Jul 17.

PMID:
17662520
7.

Treatment of localized prostate cancer using high-intensity focused ultrasound.

Uchida T, Ohkusa H, Nagata Y, Hyodo T, Satoh T, Irie A.

BJU Int. 2006 Jan;97(1):56-61.

8.

High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.

Challacombe BJ, Murphy DG, Zakri R, Cahill DJ.

BJU Int. 2009 Jul;104(2):200-4. doi: 10.1111/j.1464-410X.2009.08355.x. Epub 2009 Feb 11.

10.

[Results of transrectal focused ultrasound for the treatment of localized prostate cancer (120 patients with PSA < or + 10ng/ml].

Poissonnier L, Gelet A, Chapelon JY, Bouvier R, Rouviere O, Pangaud C, Lyonnet D, Dubernard JM.

Prog Urol. 2003 Feb;13(1):60-72. French.

PMID:
12703356
11.

First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer.

Blana A, Murat FJ, Walter B, Thuroff S, Wieland WF, Chaussy C, Gelet A.

Eur Urol. 2008 Jun;53(6):1194-201. Epub 2007 Nov 5.

PMID:
17997026
12.

High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology.

Rebillard X, Soulié M, Chartier-Kastler E, Davin JL, Mignard JP, Moreau JL, Coulange C; Association Francaise d'Urologie.

BJU Int. 2008 May;101(10):1205-13. doi: 10.1111/j.1464-410X.2008.07504.x. Epub 2008 Mar 4. Review.

13.

Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer.

Ficarra V, Antoniolli SZ, Novara G, Parisi A, Fracalanza S, Martignoni G, Artibani W.

BJU Int. 2006 Dec;98(6):1193-8.

14.

High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.

Blana A, Brown SC, Chaussy C, Conti GN, Eastham JA, Ganzer R, Murat FJ, Pasticier G, Rebillard X, Rewcastle JC, Robertson CN, Thuroff S, Ward JF.

BJU Int. 2009 Oct;104(8):1058-62. doi: 10.1111/j.1464-410X.2009.08518.x. Epub 2009 Apr 17.

15.

High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.

Blana A, Walter B, Rogenhofer S, Wieland WF.

Urology. 2004 Feb;63(2):297-300. Review.

PMID:
14972475
16.

High Intensity Focused Ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results.

Maestroni U, Ziveri M, Azzolini N, Dinale F, Ziglioli F, Campaniello G, Frattini A, Ferretti S.

Acta Biomed. 2008 Dec;79(3):211-6.

PMID:
19260381
17.

Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.

Murat FJ, Poissonnier L, Rabilloud M, Belot A, Bouvier R, Rouviere O, Chapelon JY, Gelet A.

Eur Urol. 2009 Mar;55(3):640-7. doi: 10.1016/j.eururo.2008.04.091. Epub 2008 May 9.

PMID:
18508188
18.

Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation-based technology.

Pinthus JH, Farrokhyar F, Hassouna MM, Woods E, Whelan K, Shayegan B, Orovan WL.

BJU Int. 2012 Oct;110(8):1142-8. doi: 10.1111/j.1464-410X.2012.10945.x. Epub 2012 Feb 28.

19.

Control of prostate cancer by transrectal HIFU in 227 patients.

Poissonnier L, Chapelon JY, Rouvière O, Curiel L, Bouvier R, Martin X, Dubernard JM, Gelet A.

Eur Urol. 2007 Feb;51(2):381-7. Epub 2006 May 2.

PMID:
16857310
20.

Efficacy of short-term androgen deprivation with high-intensity focused ultrasound in the treatment of prostate cancer in Japan.

Sumitomo M, Hayashi M, Watanabe T, Tsugawa M, Noma H, Yamaguchi A, Nagakura K, Hayakawa M, Uchida T.

Urology. 2008 Dec;72(6):1335-40. doi: 10.1016/j.urology.2007.12.041. Epub 2008 Mar 20.

PMID:
18355899
Items per page

Supplemental Content

Write to the Help Desk